Document 0160
 DOCN  M9490160
 TI    Systemic treatment of Kaposi's sarcoma: current status and future
       directions [editorial]
 DT    9411
 AU    Lilenbaum RC; Ratner L
 SO    AIDS. 1994 Feb;8(2):141-51. Unique Identifier : AIDSLINE MED/94318197
 DE    Acquired Immunodeficiency Syndrome/COMPLICATIONS/DRUG THERAPY
       Antineoplastic Agents/*THERAPEUTIC USE  Antineoplastic Agents,
       Combined/THERAPEUTIC USE  Antiviral Agents/THERAPEUTIC USE  Biological
       Response Modifiers/THERAPEUTIC USE  Gene Products, tat/ANTAGONISTS &
       INHIB  Hematopoietic Cell Growth Factors/THERAPEUTIC USE  Human
       Interferons/THERAPEUTIC USE  Interleukin-2/THERAPEUTIC USE  Sarcoma,
       Kaposi's/*DRUG THERAPY  Support, Non-U.S. Gov't  Support, U.S. Gov't,
       P.H.S.  EDITORIAL  REVIEW  REVIEW LITERATURE  JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).